There is provided a composition for prevention, alleviation, or treatment of atopic dermatitis diseases, a functional food and a pharmaceutical composition, each including same, and a composition for alleviation of atopic dermatitis diseases, including an Impatiens arguta extract as an active ingredient.

There is provided a composition for prevention, alleviation, or treatment of atopic dermatitis diseases, a functional food and a pharmaceutical composition, each including same, and a composition for alleviation of atopic dermatitis diseases, including an Impatiens arguta extract as an active ingredient.

There is provided a composition for prevention, alleviation, or treatment of atopic dermatitis diseases, a functional food and a pharmaceutical composition, each including same, and a composition for alleviation of atopic dermatitis diseases, including an Impatiens arguta extract as an active ingredient.

A composition for prevention, alleviation, or treatment of respiratory diseases, and a functional food and a pharmaceutical composition, each comprising same. There is also provided a composition for the enhancement of respiratory functions and the alleviation of respiratory diseases, comprising an Impatiens arguta extract as an active ingredient.

A composition for prevention, alleviation, or treatment of respiratory diseases, and a functional food and a pharmaceutical composition, each comprising same. There is also provided a composition for the enhancement of respiratory functions and the alleviation of respiratory diseases, comprising an Impatiens arguta extract as an active ingredient.

A composition for prevention, alleviation, or treatment of respiratory diseases, and a functional food and a pharmaceutical composition, each comprising same. There is also provided a composition for the enhancement of respiratory functions and the alleviation of respiratory diseases, comprising an Impatiens arguta extract as an active ingredient.

A threefold decrease in α-amylase inhibition, increase in insulin secretion and glucose uptake increase by the pharmaceutical composition of several naturally occurring substances and vitamins were observed when compared to the control cells, and a c.a. 1-1.5 fold decrease when compared to the positive control. More specifically Mix A shows significant effect on increased insulin secretion and glucose uptake by cells.

A threefold decrease in α-amylase inhibition, increase in insulin secretion and glucose uptake increase by the pharmaceutical composition of several naturally occurring substances and vitamins were observed when compared to the control cells, and a c.a. 1-1.5 fold decrease when compared to the positive control. More specifically Mix A shows significant effect on increased insulin secretion and glucose uptake by cells.

A threefold decrease in α-amylase inhibition, increase in insulin secretion and glucose uptake increase by the pharmaceutical composition of several naturally occurring substances and vitamins were observed when compared to the control cells, and a c.a. 1-1.5 fold decrease when compared to the positive control. More specifically Mix A shows significant effect on increased insulin secretion and glucose uptake by cells.

A process for obtaining enriched fractions of assets from the genus Artemisia, enriched fractions obtained by the process and bioactive composition having fraction enriched from Artemisia. The process uses extraction with supercritical fluid in which the differential consists of sequential extraction, in an unprecedented association of specific conditions and steps with an advantageous effect not previously found, thus obtaining enriched fractions of bioactives with different chemical compositions for a given application. The enriched fractions of assets of the genus Artemisia and/or its so-called bioactive compositions having fraction enriched from Artemisia obtained have application mainly in the pharmaceutical and cosmetic fields.